Free Bloomberg Terminal Alternatives That Actually Work
By Chad Hartman
Published · Last updated
A Bloomberg Terminal runs roughly $31,980 a seat per year in 2026, typically on a two-year minimum commitment, and searching for a free version of it is one of the most common queries in this entire category. The honest answer is that a free alternative exists for part of the job and not for the rest of it, and knowing which part is which saves a lot of wasted evaluation time.
The terminal bundles two very different products into one subscription: a real-time trading desk (cross-asset pricing, a messaging network, dealer quoting, execution) and a research and data layer sitting on top of it. Nothing free replaces the first. Several genuinely good free tools cover real ground on the second, and one of them is the only free tier on this list built on as-filed source data instead of a standardized representation of it.
Table of Contents
- What "Free" Actually Covers
- Finviz: Free Screening and Market Context
- StockAnalysis.com: Free Statements and Ratios
- Koyfin Free: A Real Zero-Dollar Tier
- GeminIQ Free: As-Filed Data at Zero Cost
- SEC EDGAR Directly: The Original Free Source
- What No Free Tool Replaces
- When the Free Tier Runs Out: What Each Paid Tier Costs
- What the Paid Options Cost: Capital IQ, Bloomberg, BamSEC
- Frequently Asked Questions
What "Free" Actually Covers
Bloomberg's price supports a network, not a dataset. Real-time pricing across hundreds of global exchanges, a messaging system that functions as the industry's directory, dealer quoting for instruments with no public order book, and execution wired into all of it are what a terminal seat actually buys. Every free tool below is silent on every one of those.
What a free tool can cover is research: screening a universe, reading a company's ratios and statements, and getting oriented on a name before spending real time on it. That is a genuine, well-served slice of the terminal's price tag, just not the slice most terminal subscribers are actually paying for.
Finviz: Free Screening and Market Context
Finviz's free tier is a real product, not a demo. It is used by roughly 25 million people a month, and it packs a fast screener, the best market heatmap available anywhere, and a quote page with chart, ratios, insider activity, and news onto one screen that loads instantly. Elite adds real-time data and backtesting for $299.50 a year, which is still a rounding error against a terminal seat.
The fundamental layer is thinner than the screener. It is a single row of ratios per company, with financial history capped at three years free and roughly eight years on Elite, which covers recent performance but generally not a full business cycle.
StockAnalysis.com: Free Statements and Ratios
StockAnalysis.com is the cleanest free research site available, with coverage past 130,000 symbols and free-tier statement history running to roughly five years. Pro extends that for $79 a year and Unlimited for $199, still well under one percent of a terminal seat.
The site is unusually candid about where its numbers come from: its published data-sources page names S&P Global Market Intelligence and Fiscal.ai as providers and tells users to confirm critical figures against the original filing before acting on them. That instruction is correct, and almost nobody follows it, because doing it by hand takes roughly fifteen minutes per figure.
Koyfin Free: A Real Zero-Dollar Tier
Koyfin publishes an actual $0/month tier, not a time-limited trial, with 2 years and 12 quarters of statement history alongside dashboards, watchlists, and macro data across equities, ETFs, currencies, and commodities. Paid tiers start at $39 a month and extend history to 10 years and 40 quarters.
For a generalist who wants market context in one place at zero cost, this is a genuinely strong free tier. Finviz, StockAnalysis.com, and Koyfin all share one property underneath, though: even at the free level, the fundamentals sit behind a licensed, standardized dataset rather than the filing itself.
GeminIQ Free: As-Filed Data at Zero Cost
GeminIQ's Free plan is also a genuine $0/month tier, not a trial, and it breaks the pattern above in one specific way. Every figure is still pulled directly from SEC EDGAR with the same XBRL traceability as the paid product, just scoped down rather than swapped for a different dataset. The free plan carries 3 years of historical financial data, 24 calculated metrics, next-day filing availability, and limited access to visualizations, insider transactions, institutional ownership, and price-reaction data. The Stock Screener and Custom Watchlists are reserved for paid plans.
That scoping matters less than what did not get scoped away. On Finviz, StockAnalysis.com, and Koyfin, the free tier and the paid tier sit on the same standardized data underneath, so upgrading buys more of a representation. On GeminIQ, the free tier sits on the same as-filed, XBRL-tagged pipeline as the paid product, just with three years of history and 24 metrics instead of the full library. It is the only tool on this page where a free-tier number is a reported fact rather than a standardized version of one.
SEC EDGAR Directly: The Original Free Source
For fundamental research specifically, the actual source material has always been free. Every 10-K and 10-Q is public on SEC EDGAR the moment it is filed, complete with the XBRL data behind every reported figure. No subscription gates any of it, on Bloomberg or anywhere else.
What is not free is making that data usable. Parsing a filing, resolving tag changes as the taxonomy is revised year over year, handling restatements, and assembling comparable statement history across a decade of filings is a sustained extraction problem. Free covers the documents. It does not cover the dataset, and that gap is what every research platform on this page, GeminIQ's own free tier included, is actually built to close.
What No Free Tool Replaces
None of the tools above, free or paid, touch the reason most Bloomberg subscribers actually pay. A stale quote is a losing quote for a trader, and a bond desk needs a counterparty in seconds rather than after an email thread. Large parts of the fixed income market have no public order book at all, so price discovery happens through relationships the terminal indexes. Free research tools were never built to solve that problem, and no comparison that pretends otherwise is worth reading.
If you trade, need real-time execution, or depend on the terminal's messaging network to reach counterparties, the terminal is not an expensive option. It is the job, and this post is not about that job.
When the Free Tier Runs Out: What Each Paid Tier Costs
Every free tool above eventually hits a ceiling, and the ceilings differ by what you are optimizing for. Finviz Elite and StockAnalysis Pro or Unlimited buy more history and features on top of the same licensed data underneath, so upgrading pays for convenience rather than traceability. Koyfin's paid tiers work the same way, extending statement history from 2 years and 12 quarters to 10 years and 40 quarters on the same Capital IQ-sourced fundamentals.
GeminIQ's Annual ($29/month billed annually) and Monthly ($39/month) plans extend the free plan along the same as-filed pipeline rather than switching to a different one. The upgrade unlocks 17+ years of historical data instead of three, 90+ calculated metrics instead of 24, plus the Stock Screener, Custom Watchlists, and full Insider Transactions and Institutional Ownership tracking that the free tier only shows in limited form. The upgrade adds depth and functionality. It does not add a standardization layer between the filing and the display, because there was never one to add.
Financial Statements and Calculated Metrics work identically on the free and paid GeminIQ plans in one respect: every figure traces to its SEC source either way. What changes with a subscription is how much history and how many metrics are unlocked, not whether the number on screen is the one the company actually filed. That is the distinction every free-versus-paid comparison on this page ultimately comes down to: more of the filing, never a different version of it.
For the fuller comparison against the terminal itself, the GeminIQ vs. Bloomberg Terminal comparison covers it in depth.
What the Paid Options Cost: Capital IQ, Bloomberg, BamSEC
Put side by side, the price ladder in this category spans four orders of magnitude, and the two most expensive rungs are the two that publish nothing. Every figure below is the one cited in the sections above; where a vendor does not publish a number, the table says so rather than estimating one.
| Platform | What the price buys | Published cost |
|---|---|---|
| Bloomberg Terminal | Real-time cross-asset pricing, messaging, dealer quoting, execution | Not published; widely reported near $31,980 per seat per year, roughly $28,320 per seat at two or more |
| S&P Capital IQ | The licensed, standardized fundamentals layer sitting under Koyfin and others | Not published — see our Capital IQ pricing breakdown |
| Finviz Elite | Real-time data and backtesting on top of the free screener | $299.50 a year |
| StockAnalysis.com Pro / Unlimited | More history and features on the same licensed data | $79 / $199 a year |
| Koyfin (paid) | 10 years and 40 quarters of statement history | From $39 a month |
| BamSEC | Fast navigation of one company's filings and exhibits | Not listed here |
| GeminIQ Annual / Monthly | 17+ years, 90+ metrics, Screener, Watchlists, on as-filed data | $29 / $39 a month |
| GeminIQ Free | 3 years, 24 metrics, same as-filed pipeline | $0 |
The pattern in that table is worth stating plainly: the products that do not publish a price are the ones selling access to a network and a licensing relationship, not to a dataset you could otherwise assemble. Everything below them is priced against what it costs to process filings that were already free.
Frequently Asked Questions
Are there really free Bloomberg Terminal alternatives?
For fundamental, filing-based research, yes. Finviz, StockAnalysis.com, Koyfin, and GeminIQ all offer real, permanent free tiers covering screening, ratios, statements, and market context at no cost, and the underlying SEC filings themselves have always been free on EDGAR. None of them touch the terminal's real-time trading, messaging, or execution functions, which is what most of a terminal seat's price actually pays for.
What does a Bloomberg Terminal cost in 2026?
Bloomberg does not publish pricing, but widely reported figures put a single seat near $31,980 per year in 2026, dropping to roughly $28,320 per seat for firms running two or more, typically on a two-year minimum commitment.
Is GeminIQ free?
Yes, in a genuine and permanent form. GeminIQ's Free plan is $0 a month with no trial required, covering 3 years of as-filed financial history and 24 calculated metrics, sourced directly from SEC EDGAR with the same XBRL traceability as the paid product. The Stock Screener, Custom Watchlists, and full 17-plus-year history are reserved for the Annual ($29/month billed annually) and Monthly ($39/month) plans, both of which include a 7-day free trial.
Which free tool is closest to a Bloomberg Terminal for stock research?
None of them are close on breadth, and that is the wrong comparison to make. For screening and market context, Finviz and Koyfin's free tier are the strongest no-cost options. For statement-level research with source traceability rather than standardized data, GeminIQ's free tier and SEC EDGAR directly go deepest, though EDGAR requires doing the extraction work by hand.
Is there a free alternative to S&P Capital IQ?
Not to the full institutional stack, but the part most individual investors actually want from it — standardized statement history — is available free from several tools on this page. Koyfin's free tier runs on Capital IQ-sourced fundamentals directly, and GeminIQ's Free plan covers 3 years of as-filed history and 24 calculated metrics at $0. What Capital IQ itself costs is a separate question with a longer answer, covered in our S&P Capital IQ pricing breakdown.
What should QuickFS users switch to now that it has shut down?
QuickFS has shut down, and its homepage now carries a farewell note from founder Ted Cooper pointing users to FastFS.org. For anyone rebuilding a workflow around it, the choice comes down to the same split this page is about. If what mattered was standardized statement history in a fast interface, StockAnalysis.com and Koyfin's free tier cover that at no cost. If what mattered was being able to trace a figure back to the filing that produced it, that is a different category, and GeminIQ's Free plan carries 3 years of as-filed, XBRL-tagged history and 24 calculated metrics at $0.
Wall Street's data. Main Street's price.
Institutional terminals charge thousands a year for as-filed accuracy. GeminIQ gives you the same thing for a fraction of the cost: financials built directly from raw SEC EDGAR filings, not third-party APIs, with full XBRL traceability back to the original 10-K or 10-Q. No normalized guesswork, just calculated metrics, charts, screeners, and watchlists built on numbers exactly as the company reported them. Start researching now at GeminIQ.com.
Data Used / Sources
- Fundamental data sourced from XBRL-tagged SEC filings via GeminIQ.
- Bloomberg Terminal per-seat cost figures are widely reported third-party estimates compiled from procurement trackers and subscriber reports; Bloomberg does not publish pricing.
- Finviz, StockAnalysis.com, and Koyfin free-tier features, history limits, and paid-tier pricing are drawn from GeminIQ's own published comparison research on each platform (linked above), reviewed August 2, 2026 from each platform's public materials.
- GeminIQ Free, Annual, and Monthly plan features, limits, and pricing confirmed directly from https://www.geminiq.com/pricing, retrieved August 7, 2026.
- GeminIQ Bloomberg Terminal comparison page: /competitor-comparison/bloomberg-terminal
Disclaimer: The content in this blog is for educational and entertainment purposes only and does not constitute financial, legal, or tax advice. Investing involves risk, including the loss of principal. The views expressed are my own and not intended as financial advice or a guarantee of future performance.